Welcome Moderna Inc.!

Welcome Moderna Inc.!

Meet new CFD instrument on Moderna Inc. securities, is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts. It focuses on drug discovery, drug development, and vaccine technologies based on messenger RNA (mRNA). Moderna's technology platform inserts synthetic nucleoside-modified mRNA (modRNA) into human cells. This mRNA then reprograms the cells to prompt immune responses. It is a novel technique, abandoned by other manufacturers because of the side effects of repeatedly inserting mRNA into cells by way of lipid nanoparticles, which were found by the other manufacturers to become cytotoxic. Find MRNA at the trading platform in CFD on the NASDAQ group. Watch trading specifications before making trades. We wish you successful trading!

Before you start!

Our services include products that are traded on margin and carry a risk that you can lose more than your initial deposit. The products may not be suitable for everyone. Please ensure you fully understand the risks involved. There is a high level of risk involved with trading leveraged products such as different contracts on difference on currency pairs, crypto-assets, commodities, securities, etc. You should not risk more than you can afford to lose! It is possible that you may lose more than your initial investment. You should not trade unless you fully understand the true extent of your exposure to the risk of loss. When trading, you must always take into consideration your level of experience. It is the responsibility of the client to ensure that the client can accept the services and/or enter into the transactions in the country in which the client is resident. If the risks involved seem unclear to you, please seek independent advice. Read our Risk disclosure statement and the Responsible attitude policy to get more information about potential risks.